Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Experimental Oncology
|
June 25, 2009
Assessment of anthracycline-induced cardiotoxicity with electrocardiography
J M Horacek, M Jakl, J Horackova, et al.
Casopis Lekaru Ceskych
|
July 29, 2010
[Multi-marker approach in the diagnostics of cardiac diseases by protein biochip technology]
M Vasatová, M Tichý, J M Horácek, et al.
Experimental Oncology
|
August 10, 2010
The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia
J M Horacek, M Vasatova, M Tichy, et al.
Experimental Oncology
|
June 21, 2008
Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia
J M Horacek, M Tichy, L Jebavy, et al.
International Journal of Cardiology
|
May 30, 2001
The prognostic significance of intermediate QRS prolongation in acute myocardial infarction
R Pudil, M S Feinberg, H Hod, et al.
Experimental Oncology
|
January 18, 2008
Assessment of anthracycline-induced cardiotoxicity with biochemical markers
J M Horacek, R Pudil, L Jebavy, et al.
Virchows Archiv : an International Journal of Pathology
|
June 12, 2008
Re-expression of nestin in the myocardium of postinfarcted patients
J Mokry, R Pudil, J Ehrmann, et al.
Acta Medica (Hradec Kralove)
|
January 1, 1996
The effect of reperfusion on plasma tumor necrosis factor alpha and C reactive protein levels in the course of acute myocardial infarction
R Pudil, V Pidrman, J Krejsek, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 25, 1999
Cytokines and adhesion molecules in the course of acute myocardial infarction
R Pudil, V Pidrman, J Krejsek, et al.
Physiological Research
|
November 26, 2009
Application of proteomics in biomarker discovery: a primer for the clinician
V Tambor, A Fučíková, J Lenco, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Experimental Oncology
|
June 25, 2009
Assessment of anthracycline-induced cardiotoxicity with electrocardiography
J M Horacek, M Jakl, J Horackova, et al.
Casopis Lekaru Ceskych
|
July 29, 2010
[Multi-marker approach in the diagnostics of cardiac diseases by protein biochip technology]
M Vasatová, M Tichý, J M Horácek, et al.
Experimental Oncology
|
August 10, 2010
The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia
J M Horacek, M Vasatova, M Tichy, et al.
Experimental Oncology
|
June 21, 2008
Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia
J M Horacek, M Tichy, L Jebavy, et al.
International Journal of Cardiology
|
May 30, 2001
The prognostic significance of intermediate QRS prolongation in acute myocardial infarction
R Pudil, M S Feinberg, H Hod, et al.
Experimental Oncology
|
January 18, 2008
Assessment of anthracycline-induced cardiotoxicity with biochemical markers
J M Horacek, R Pudil, L Jebavy, et al.
Virchows Archiv : an International Journal of Pathology
|
June 12, 2008
Re-expression of nestin in the myocardium of postinfarcted patients
J Mokry, R Pudil, J Ehrmann, et al.
Acta Medica (Hradec Kralove)
|
January 1, 1996
The effect of reperfusion on plasma tumor necrosis factor alpha and C reactive protein levels in the course of acute myocardial infarction
R Pudil, V Pidrman, J Krejsek, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 25, 1999
Cytokines and adhesion molecules in the course of acute myocardial infarction
R Pudil, V Pidrman, J Krejsek, et al.
Physiological Research
|
November 26, 2009
Application of proteomics in biomarker discovery: a primer for the clinician
V Tambor, A Fučíková, J Lenco, et al.
Page
of 5